Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21020565 | 0.86 | GAA (0.35) | DHFR | |
| SCHEMBL20650725 | 0.85 | TNKS (0.32) | TNKSPARP1TNKS2HDAC6PARP2 | |
| SCHEMBL21021025 | 0.85 | DHFR (0.34) | DHFRTNKSPARP1TNKS2HDAC6 | |
| SCHEMBL20800889 | 0.85 | TNKS (0.35) | DHFRTNKSPARP1TNKS2HDAC6 | |
| SCHEMBL21020278 | 0.84 | NPC1 (0.36) | — | |
| SCHEMBL21020298 | 0.83 | KDM4C (0.36) | DHFRTNKSPARP1TNKS2HDAC6 | |
| SCHEMBL21021032 | 0.83 | DHFR (0.35) | DHFRTNKSPARP1TNKS2HDAC6 | |
| SCHEMBL18627678 | 0.82 | TNKS (0.41) | DHFRTNKSPARP1TNKS2HDAC6 | |
| SCHEMBL21020570 | 0.82 | KDM4C (0.30) | — | |
| SCHEMBL20800890 | 0.82 | DHFR (0.32) | DHFRTNKSPARP1TNKS2HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | DHFR 1559/4885TNKS 4534/4885PARP1 4473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.